NearWave

NearWave

Private
South Bend, IndianaHealthcare & Life Scienceshttps://nearwave.co

Last Round

Seed

Jul 20, 2023

Total Funding Raised

$1.86M

Momentum Score

25 /100

Company Overview

NearWave is a medical technology company that has developed a handheld, non-invasive imaging device to assess vital biomarkers in deep tissue. The device uses near-infrared laser light to measure tissue oxygen saturation and hemoglobin concentrations, with an initial focus on monitoring breast cancer therapy and aiding in early screening. By analyzing tissue composition, the technology aims to quickly determine the effectiveness of treatments like chemotherapy, potentially within a week, rather than the months it currently takes. This allows physicians to make rapid adjustments to a patient's treatment plan, saving them from the side effects of ineffective therapies. The company was founded in 2020 by Roy Stillwell and Professor Thomas O'Sullivan at the University of Notre Dame.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting

AI Layer

Non-AI

Keywords

breast cancer monitoringchemotherapy monitoringhandheld medical scannerfdNIRSfrequency domain near-infrared spectroscopynon-invasive monitoringnear-infrared spectroscopyNIRStumor response monitoringtissue biomarker measurementoptical medical imagingoncology diagnosticsprecision medicinebiophotonicsmedtechmedical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NearWave Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

NearWave Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedJul 20, 2023
Pre SeedJun 15, 2022
GrantMay 19, 2022
AcceleratorMar 10, 2022
Pre SeedSep 22, 2021
Pre Seed
Dec 8, 2020

Key People

Founding team and executive leadership

Roy A. Stillwell

CEO

Executive Team

NearWave Investors

Notable investors and investment history

InvestorRounds
ASU eSeed ChallengeGrant
Elevate VenturesPre Seed
CANCER FUNDSeed
Texas Medical CenterSeed
Y CombinatorPre Seed, Seed, Accelerator
Flywheel FundPre Seed, Seed
Tampa Bay WaveSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 19, 2026

    Monthly visitors grew 33% MoM, reaching 1.3K.

NearWave Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NearWave Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NearWave's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth Bend, Indiana
Employee Range5
Year Founded2020
Last FundingJul 20, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.